Table 3.
Sample and time point | Skewness (SE) | Baseline symptoms, mean (SD) | Effect size, Cohen d (95% CI) | |
Treatment sample (n=1098) |
|
|
1.27 (1.21 to 1.34) | |
|
Pretreatment | 0.271 (0.071)a | 11.73 (4.83) |
|
|
Posttreatment | 1.359 (0.076)a | 5.60 (4.58) |
|
Control sample depression (n=96) |
|
|
–0.04 (–0.24 to 0.16) | |
|
Pretreatment | 0.178 (0.109) | 10.91 (4.53) |
|
|
Posttreatment | 0.228 (0.109) | 11.00 (5.04) |
|
aStatistical significance beyond .05 alpha on a Shapiro-Wilk test for distribution normality; significance is indicative that normal distribution is not supported within the observed sample.